Granted Patent
B2
US 9,383,357 · App. 14/099,444 · Granted Jul 5, 2016
Biomarker for replicative senescence
Inventors:
Robert D. Goldman (Chicago, IL); Takeshi Shimi (Chicago, IL); Stephen A. Adam (Glenview, IL)
Assignee:
NORTHWESTERN UNIVERSITY
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides biomarkers for replicative senescence. In particular, Lamin B1 is provided as a biomarker for replicative senescence.
Claims (4)
1. A method comprising:
(a) contacting a population of chemically-fixed human cells comprising both proliferating and senescent cells with non-human antibodies that specifically bind human lamin B1 (anti-LB 1 antibodies) under conditions which result in formation of a complex between the anti-LB 1 antibodies and human lamin B1 present on cells within the population, wherein said anti-LB 1 antibodies bind to lamin B1, but not to Lamin B2 and Lamin A/C;
(b) binding fluorophore-tagged secondary antibodies to said anti-LB 1 antibodies; and
(c) detecting fluorescence from said fluorophore.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 2, 2014
From: GOLDMAN, ROBERT D.; SHIMI, TAKESHI; ADAM, STEPHEN A.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 031879/0502 →
CONFIRMATORY LICENSE
Recorded Dec 23, 2013
From: NORTHWESTERN UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031867/0927 →
Continuity (2)
Provisional Application
61734676
· Dec 7, 2012